Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023)
Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -43.42% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -11.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 27.22% |
| 10 | Biomerica | 6.20 Mn | 4.87 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -75.00% |
| Aug 31, 2023 | -38.24% |
| Feb 28, 2023 | -58.14% |
| Nov 30, 2022 | 83.61% |
| Aug 31, 2022 | 561.35% |
| May 31, 2022 | -15.96% |
| Feb 28, 2022 | -68.28% |
| Nov 30, 2021 | -40.53% |
| Aug 31, 2021 | -87.01% |
| May 31, 2021 | 394.49% |
| Feb 28, 2021 | 111.18% |
| Nov 30, 2020 | 429.34% |
| Aug 31, 2020 | 1,723.49% |
| May 31, 2020 | -79.13% |
| Feb 29, 2020 | 7.72% |
| Nov 30, 2019 | -72.32% |
| Aug 31, 2019 | -94.30% |
| May 31, 2019 | -49.70% |
| Feb 28, 2019 | -7.08% |
| Nov 30, 2018 | -54.48% |